Haplotypes by fibrosis | Frequency | OR (95 % CI) | p valuea | aOR (95 % CI) | p valueb | |
---|---|---|---|---|---|---|
F < 2 (%) | F ≥ 2 (%) | |||||
CT | 49.5 | 47.0 | 0.88 (0.61–1.28) | 0.509 | 0.91 (0.62–1.34) | 0.627 |
GT | 34.8 | 35.7 | 1.05 (0.71–1.55) | 0.818 | 1.03 (0.68–1.54) | 0.902 |
GA | 8.6 | 8.2 | 0.94 (0.46–1.95) | 0.876 | 0.88 (0.41–1.89) | 0.749 |
CA | 7.1 | 9.1 | 1.43 (0.69–2.95) | 0.321 | 1.52 (0.68–3.37) | 0.294 |
Haplotypes by HCV treatment response | Non-SVR (%) | SVR (%) | OR (95 % CI) | p valuea | aOR (95 % CI) | p valueb |
---|---|---|---|---|---|---|
CT | 50.7 | 46.5 | 0.82 (0.58–1.15) | 0.244 | 0.78 (0.51–1.18) | 0.236 |
GT | 36.5 | 33.3 | 0.84 (0.58–1.21) | 0.345 | 0.86 (0.55–1.34) | 0.496 |
GA | 7.0 | 10.0 | 1.81 (0.90–3.61) | 0.090 | 1.61 (0.67–3.88) | 0.286 |
CA | 5.9 | 10.2 | 2.29 (1.12–4.70) | 0.018 | 2.80 (1.19–6.57) | 0.013 |